These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6124899)

  • 21. Acute anticholinergic action in focal dystonia.
    Lang AE; Sheehy MP; Marsden CD
    Adv Neurol; 1983; 37():193-200. PubMed ID: 6134443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromocriptine and lisuride in dystonias.
    Obeso JA; Luquin MR
    Neurology; 1984 Jan; 34(1):135-6. PubMed ID: 6537848
    [No Abstract]   [Full Text] [Related]  

  • 23. [Doctor, I need an antidote for your antidote. A case biperidene induced anticholinergic syndrome].
    Carabaño Aguado I; Pelayo Baeza F; González-Valcárcel Sánchez-Puelles J
    An Pediatr (Barc); 2010 May; 72(5):368-9. PubMed ID: 20378434
    [No Abstract]   [Full Text] [Related]  

  • 24. BMY-14802 reversed the sigma receptor agonist-induced neck dystonia in rats.
    Okumura K; Ujike H; Akiyama K; Kuroda S
    J Neural Transm (Vienna); 1996; 103(10):1153-61. PubMed ID: 9013402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs.
    Luchins DJ; Freed WJ; Wyatt RJ
    Am J Psychiatry; 1980 Nov; 137(11):1395-8. PubMed ID: 6108078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bromocriptine and amantadine in cocaine detoxification.
    Giannini AJ; Folts DJ; Feather JN; Sullivan BS
    Psychiatry Res; 1989 Jul; 29(1):11-6. PubMed ID: 2672061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bromocriptine for "negative" schizophrenia.
    Levi-Minzi S; Bermanzohn PC; Siris SG
    Compr Psychiatry; 1991; 32(3):210-6. PubMed ID: 1679383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose bromocriptine in a case of tardive dystonia.
    Luchins DJ; Goldman M
    Biol Psychiatry; 1985 Feb; 20(2):179-81. PubMed ID: 2857580
    [No Abstract]   [Full Text] [Related]  

  • 29. Bromocriptine in dystonia.
    Stahl SM; Berger PA
    Lancet; 1981 Oct; 2(8249):745. PubMed ID: 6116872
    [No Abstract]   [Full Text] [Related]  

  • 30. Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin.
    Flores CM; Hulihan-Giblin BA; Hornby PJ; Lumpkin MD; Kellar KJ
    Neuroendocrinology; 1992 May; 55(5):519-28. PubMed ID: 1350068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
    Ushijima I; Tsutsumi C; Hara T; Soeda K; Kishimoto O; Kaneyuki H; Mizuki Y; Yamada M
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):463-70. PubMed ID: 2907957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effects of flunitrazepam in dystonias and torticollis. Preliminary communication.
    Marino Júnior R; Benabou R; Benabou S
    Arq Neuropsiquiatr; 1993 Jun; 51(2):285-6. PubMed ID: 8274097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Severe dystonia syndrome successfully treated with bromocriptine and ataxia-telangiectasia syndrome in a single family].
    Theau D; Missoum A
    Arch Fr Pediatr; 1986; 43(7):538. PubMed ID: 3800570
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
    Ringwald E
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Nov; 11(6):294-8. PubMed ID: 33397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time course of distant effects of local injections of botulinum toxin.
    Garner CG; Straube A; Witt TN; Gasser T; Oertel WH
    Mov Disord; 1993; 8(1):33-7. PubMed ID: 8380486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medical treatment of dystonia].
    Kachi T
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1181-2. PubMed ID: 12235832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of muscarinic receptor agonists and phorbol ester on muscarinic and D2-dopamine release-modulatory receptors.
    Hoffmann IS; Talmaciu RK; Aquino R; Cubeddu LX
    J Pharmacol Exp Ther; 1996 Aug; 278(2):662-8. PubMed ID: 8768717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
    Parkes JD; Debono AG; Marsden CD
    J Neurol Neurosurg Psychiatry; 1976 Nov; 39(11):1101-8. PubMed ID: 1036999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
    Sprah L; Zivin M; Sket D
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.